Lawyersandsettlements.com is reporting that the average payout is in excess of $1.2 million for each family that brought a lawsuit against the manufacturer for alleged heart defects and other side effects suffered by their children.
You may recall that Glaxo initially contested that Paxil had anything to do with heart defects in children when they defended themselves in the Kilker v GSK trial - a trial that they lost, appealed against, and, it is believed, eventually settled.
$1.2 Million is a huge amount of money for these poor families - it is nowhere near what Glaxo should be liable for - no price can be put on any child being born with defects.
My thoughts go out to young Manie Edgington [6] - He was born with serious heart defects and is going through a pretty bad time at the moment. He's a fighter and sent me a lovely personal message some time ago.
Thinking of you little fella - you rock!
GlaxoSmithKline are back in the courts later this year in the UK.
The defining issues of this group action are thus:
Does Seroxat have a capacity to cause adverse effects consequent upon or following discontinuance (withdrawal) such as prevent or make more difficult the ability of users to discontinue, withdrawal from or remain free from taking Seroxat to a greater extent than all other Selective Serotonin Re-uptake Inhibitors (SSRIs)
Glaxo are contesting this.
Fid
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
No comments: